May 22, 2017
FOR IMMEDIATE RELEASE
G1.5 KymeneTM 1500LV, a new generation of wet-strength resin, delivers high performance, high solids and low VOC in accordance with recent compliance standards and government regulations.
WILMINGTON, Del. (USA) — Solenis, a leading global producer of specialty chemicals, has introduced a new generation of wet-strength resin, G1.5 KymeneTM 1500LV, to help tissue and towel manufacturers in North America address a full range of compliance needs while providing cost-in-use efficiency.
Responding to the implementation of the GHS (Global Harmonized System for classification of chemicals) and further market demands and the decision of major retailers to reduce Priority Chemicals from their sourcing initiatives, Solenis has intensified its efforts by introducing new chemistries that deliver more concentrated products and reduce volatile organic compound (VOC) content. The new generation of Kymene resin is part of this initiative.
"Solenis has a strong history of commitment to sustainable development. As we continue to introduce new and improved generations of Kymene resin and other Solenis products, our goal is to help customers increase product quality, drive enhanced productivity and reduce costs", said Richard Cho, global marketing director, Tissue and Towel.
G1.5 allows existing Solenis G1 users to move to a cleaner product in a more cost-efficient manner without sacrificing quality. Compared to G1 wet-strength resins, G1.5 resins have lower levels of hazardous, possibly carcinogenetic VOCs, including 1,3-dichloropropanol (1,3-DCP), 3-monochloropropan-1,2-diol (3-MCPD), aminochlorohydrin (ACH), polymer-bound CPD (PB-CPD) and total adsorbable organic halogens (AOX). At the same time, they deliver high solids, high performance, and have excellent storage stability.
Solenis has created a wide range of Kymene products to meet the varying regional requirements and budgets of tissue and towel producers. G1.5 wet-strength resins are a good option for papermakers who need higher solids and low VOC but do not need the advanced quality of the company's G2, G2.5 and G3 technologies.
“The goal with every new generation of Kymene wet-strength has been to increase functionality while improving health and safety objectives,” said Jerome Banaszynski, marketing manager, Tissue and Towel, North America. “Our full family of Kymene products gives customers more flexibility to build a cost-effective wet-strength program along a pathway of incremental improvements. The G1.5 product is a great next step for our G1 customers wanting to adapt to changing industry requirements while delivering products that are both functional and safe for consumers.”
Kymene resin benefits from a robust supply chain. Solenis operates four manufacturing plants across the U.S., all of which produce G1.5 Kymene 1500LV resin within easy reach of any mill in North America.
This year marks the 60th anniversary of the discovery of a chemical additive that has helped to facilitate the change from acid to neutral pH papermaking conditions. With Kymene, Solenis invented polyamidoamine-epichlorohydrin (PAE) resins in the 1957 and has continuously improved the product. Kymene wet-strength additives work during the curing process to help papermakers improve the wet strength of grades intended primarily for the consumer market. They provide a number of value-added benefits, including improved wet strength, improved retention and drainage, enhanced creping control, improved dry strength, reduced chemical costs and improved machine efficiency.
For more information about the Solenis family of Kymene wet-strength resins, visit https://solenis.com/en/industries/tissue-towel/innovations/kymene-wet-strength-additives/.
Solenis is a leading global producer of specialty chemicals focused on delivering sustainable solutions for water-intensive industries, including the pulp, packaging paper and board, tissue and towel, oil and gas, petroleum refining, chemical processing, mineral processing, biorefining, power, municipal, and pool and spa markets. Owned by Platinum Equity, the company’s product portfolio includes a broad array of water treatment chemistries, process aids and functional additives, as well as state-of-the-art monitoring and control systems. These technologies are used by customers to improve operational efficiencies, enhance product quality, protect plant assets, minimize environmental impact and maintain healthy water. Headquartered in Wilmington, Delaware, the company has 48 manufacturing facilities strategically located around the globe and employs a team of over 6,400 professionals in 120 countries across five continents. Solenis is a 2022 US Best Managed Company.
For additional information about Solenis, please visit www.solenis.com or follow us on social media.
FOR FURTHER INFORMATION
Vice President, Corporate Communications